Gut microbiota-derived metabolite trimethylamine N-oxide and biomarkers of inflammation are linked to endothelial and coronary microvascular function in patients with inflammatory bowel disease

Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome

(2018) Arnau Vich Vila et al.   Science Translational Medicine

The Carnitine-butyrobetaine-trimethylamine-N-oxide pathway and its association with cardiovascular mortality in patients with carotid atherosclerosis

(2016) Karolina Skagen et al.   ATHEROSCLEROSIS

Role of gut microbiota in atherosclerosis

(2016) Annika Lindskog Jonsson et al.   Nature Reviews Cardiology

Trimethylamine N‐Oxide Promotes Vascular Inflammation Through Signaling of Mitogen‐Activated Protein Kinase and Nuclear Factor‐κB

(2016) Marcus M. Seldin et al.   Journal of the American Heart Association

Previous gestational diabetes history is associated with impaired coronary flow reserve

(2015) Mustafa Caliskan et al.   ANNALS OF MEDICINE

Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

(2015) Aze Wilson et al.   DIGESTIVE DISEASES AND SCIENCES

Impaired coronary microvascular and left ventricular diastolic function in patients with inflammatory bowel disease

(2015) Zuhal Caliskan et al.   MICROVASCULAR RESEARCH

Inflammatory bowel disease and risk of coronary heart disease

(2015) Christine Rungoe et al.   TRENDS IN CARDIOVASCULAR MEDICINE

Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine- N -Oxide

(2015) Kymberleigh A. Romano et al.   mBio

Dysbiosis of Gut Microbiota With Reduced Trimethylamine‐N‐Oxide Level in Patients With Large‐Artery Atherosclerotic Stroke or Transient Ischemic Attack

(2015) Jia Yin et al.   Journal of the American Heart Association

Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis

(2015) Italia Loddo et al.   Frontiers in Immunology

Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure

(2014) W.H. Wilson Tang et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Impaired coronary microvascular function and increased intima–media thickness in preeclampsia

(2014) Faika C. Ciftci et al.   Journal of the American Society of Hypertension

The genetics of Crohn’s disease and ulcerative colitis –status quoand beyond

(2014) David Ellinghaus et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk

(2013) W.H. Wilson Tang et al.   NEW ENGLAND JOURNAL OF MEDICINE

Are Patients with Inflammatory Bowel Disease at Increased Risk of Coronary Artery Disease?

(2012) Sumeet Gandhi et al.   AMERICAN JOURNAL OF MEDICINE

Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment

(2012) Xochitl C Morgan et al.   GENOME BIOLOGY

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

(2011) Zeneng Wang et al.   NATURE

Enhand secretion of tumour necrosis factor-alpha, IL-6, and IL-1β by isolated lamina ropria monouclear cells from patients with ulcretive cilitis and Crohn's disease

(2010) H.-C. REINECKER et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Enteric defensins are essential regulators of intestinal microbial ecology

(2009) Nita H Salzman et al.   NATURE IMMUNOLOGY

Evidence of Endothelial Dysfunction in Patients With Inflammatory Bowel Disease

(2008) Idan Roifman et al.   Clinical Gastroenterology and Hepatology

Targeted Epithelial Tight Junction Dysfunction Causes Immune Activation and Contributes to Development of Experimental Colitis

(2008) Liping Su et al.   GASTROENTEROLOGY